pre-ipo
Stage
2
Investors
About
Turning Point Therapeutics is a clinical-stage precision oncology company developing targeted therapies for cancer patients with genetically defined tumors.
Explore Turning Point Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.